Partner Fund Management »

Edwards Lifesciences shares owned by Partner Fund Management

Quarter-by-quarter ownership of Edwards Lifesciences (EW) shares owned by Partner Fund Management from 13F filings

Historical chart of Partner Fund Management investment in Edwards Lifesciences

Tip: Access up to 7 years of quarterly data

All positions including Edwards Lifesciences held by Partner Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Edwards Lifesciences by Partner Fund Management

Quarter filed Position value Share count Share price at filing
2011-03-31 $42M 477k 87.00
2010-12-31 $12M 148k 80.84

More positions owned by Partner Fund Management

Eli Lilly & Co. (LLY)
Cytokinetics Com New (CYTK)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tenet Healthcare Corp Com New (THC)
Merck & Co (MRK)
Vertex Pharmaceuticals Incorporated (VRTX)
Abbvie (ABBV)
Edwards Lifesciences (EW)
UnitedHealth Call Option (UNH)
Intuitive Surgical Com New (ISRG)
McKesson Corporation (MCK)
Spdr Ser Tr S&p Biotech Call Option (XBI)
Humana (HUM)
Hca Holdings (HCA)
Centene Corporation (CNC)

View all positions for Partner Fund Management

Top funds holding Edwards Lifesciences

Vanguard Group
BlackRock
State Street Corporation
Alliancebernstein
Bank of New York Mellon
Brown Advisory Holdings Incorporated
Geode Capital Management
Jpmorgan Chase & Co
Fisher Investments
T. Rowe Price Associates
Morgan Stanley
Invesco
Henderson Group
Winslow Capital Management
Wellcome Trust Limited, as Trustee of the Wellcome Trust

View all funds holding Edwards Lifesciences